Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Locus of crossover in P1 (loxP) site is a 34-base pair DNA sequence derived from the bacteriophage P1, consisting of two 13-bp inverted repeats flanking an 8-bp asymmetric spacer region (Sauer, B., Mol Cell Biol, 1987). It serves as the specific recognition substrate for Cre recombinase, an enzyme that catalyzes site-specific DNA recombination between two such sites (Nagy, A., Genesis, 2000). In the context of transduced Postn-expressing cells, these sites are typically integrated into the genome of cells expressing Periostin (Postn), a protein primarily associated with the extracellular matrix and activated fibroblasts during tissue repair, cardiac remodeling, and fibrosis (Takeda, N., et al., J Clin Invest, 2010). This experimental configuration allows for the conditional deletion, inversion, or translocation of specific genetic sequences within the Postn-positive cell lineage, providing a powerful tool for lineage tracing and functional genomics in cardiovascular and fibrotic disease research (Kuhn, R., & Schwenk, F., Methods Mol Biol, 1997). While loxP sites are not endogenous human therapeutic targets, they are essential components of gene therapy strategies and preclinical models designed to modulate gene expression in a cell-type-specific manner. Therapeutic challenges for clinical translation include the potential for off-target recombination at 'pseudo-loxP' sites in the human genome and the potential immunogenicity of the bacterial Cre protein.
Cre-mediated site-specific recombination between two loxP sites to induce DNA deletion, inversion, or translocation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Locus of crossover in P1 site (loxP) (loxP).